Clinical trials recruiting in Zhuhai, China

Phase breakdown

Conditions recruiting in Zhuhai, China

Recruiting trials in Zhuhai, China

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
  NCT05188885 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
  NCT06952803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
  NCT07098338 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
  NCT05837897 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female)
• A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
  NCT06210776 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
  NCT06471257 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• ASPIrin in Reducing Events in Dialysis ( ASPIRED )
  NCT04381143 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
  NCT06551220 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: Female
• Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
  NCT07516184 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
  NCT04263298 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female
• Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
  NCT06966908 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
  NCT06314282 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• PEI-GT Trial for Initial Treatment of Primary Open-Angle Glaucoma With Cataract
  NCT07700498 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 85 Years · Sex: All (male and female)
• Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
  NCT05024214 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
  NCT05523245 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)
  NCT07416474 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
  NCT07181499 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
  NCT05866029 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 90 Years · Sex: All (male and female)
• cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
  NCT06686485 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Zhuhai, China?

22 recruiting trials have at least one study site in Zhuhai, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.